Back
Denali Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
60
DNLI
Denali Therapeutics
Last Price:
28.84
Seasonality Move:
6.34%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- The current trend is moderately bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.56 | Buy |
| 20-day SMA: | 27.91 | Buy |
| 50-day SMA: | 28.09 | Buy |
| 200-day SMA: | 22.26 | Buy |
| 8-day EMA: | 29.55 | Buy |
| 20-day EMA: | 28.55 | Buy |
| 50-day EMA: | 27.49 | Buy |
| 200-day EMA: | 24.13 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 57.2 | Buy |
| Chaikin Money Flow: | -842351 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.07 - 29.31) | Buy |
| Bollinger Bands (100): | (22.66 - 28.54) | Buy |
Denali Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 29.64 while DNLI 8-day simple moving average is 29.56, which is a Buy signal.
- The stock price of DNLI is 29.64 while Denali Therapeutics 20-day SMA is 27.91, which makes it a Buy.
- Denali Therapeutics 50-day simple moving average is 28.09 while DNLI share price is 29.64, making it a Buy technically.
- DNLI stock price is 29.64 and Denali Therapeutics 200-day simple moving average is 22.26, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Buy
60
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Buy
The current Denali Therapeutics [DNLI] share price is $29.64. The Score for DNLI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Denali Therapeutics Stock Info
Market Cap:
4.27B
Price in USD:
29.64
Share Volume:
1.59M
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
14.56
Buy
60
Denali Therapeutics (DNLI)
is a Buy
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 29.64 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is not overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 29.64 while DNLI 8-day exponential moving average is 29.55, which is a Buy signal.
- The stock price of DNLI is 29.64 while Denali Therapeutics 20-day EMA is 28.55, which makes it a Buy.
- Denali Therapeutics 50-day exponential moving average is 27.49 while DNLI share price is 29.64, making it a Buy technically.
- DNLI stock price is 29.64 and Denali Therapeutics 200-day simple moving average is 24.13, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is 0.78, suggesting Denali Therapeutics is a Buy
- Denali Therapeutics Relative Strength Index (RSI) is 57.2, which suggest Denali Therapeutics is overbought
- The Bollinger Bands (25) for Denali Therapeutics is (26.07 - 29.31), which suggest Denali Therapeutics is a Buy
- The Bollinger Bands (100) for Denali Therapeutics is (22.66 - 28.54), which suggest Denali Therapeutics is a Buy
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.